AustraliaÚltimas notícias

On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report. - Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn't need to conduct additional studies of the drug. - SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.

Alamos Gold CEO John McCluskey joins Bloomberg Open Interest to explain the seismic disruption behind the company's production cut, why he sees the setback as temporary, and why he rejects the idea that a weaker share price makes Alamos an M&A target.

Former Fed Governor Randy Kroszner joined Bloomberg Open Interest to break down Alan Greenspan's complicated legacy crediting him for fueling America's economic boom while acknowledging the risks that helped lead to the 2008 financial crisis. He also explains why the next era of the Federal Reserve could feature simpler communication and a renewed focus on long-term economic trends.

Republican Senator Dave McCormick of Pennsylvania joins "Bloomberg Surveillance" to discuss the current state of negotiations with Iran, the death of Alan Greenspan and how the Federal Reserve will operate under its new Chairman Kevin Warsh.

Tarek Robbiati, CFO of data storage company Everpure, said that the increased capex spend on AI is 'not temporary' even if the industry supply and demand equation rebalances and more AI capacity becomes available. Robbiati said that while the AI market is expected to revert to a mean, it will not happen quickly and it may not go back to the same level.

US Vice President JD Vance says "we laid a very good foundation for a successful final deal." He spoke to reporters in Switzerland after holding talks with Iranian negotiators.

Seema Shah, Principal Asset Management chief global strategist, discusses the near-term inflationary impact of the AI capital expenditure cycle, emphasizing that its implications remain underappreciated by investors. She speaks on "Bloomberg Surveillance."

SpaceX is selling investment-grade bonds for the first time to fund the company's AI ambitions following its record IPO. Ed Ludlow has more on "Bloomberg Open Interest."

US Vice President JD Vance says a good foundation has been laid to end the war with Iran, but more work needs to be done. He spoke to reporters in Switzerland on Monday morning. Bloomberg's Tyler Kendall reports.

Lori Calvasina, head of US equity strategy research at RBC Capital Markets, says the strength of US corporate earnings is propping up stocks amid concern that the Federal Reserve will raise interest rates. But there are limits to how many hikes the market can withstand, she says on Bloomberg Television's ``Surveillance.''

Alan Greenspan has died at the age of 100. He served as Fed chief for 18 years, from 1987 to 2006, and was credited with guiding a record US economic expansion, but his legacy was later dimmed by the financial crisis that erupted in 2008. Greenspan died on June 22 at his home due to complications of Parkinson's disease. Bloomberg's David Westin looks back at his accomplishments.

Amundi Investment Institute Head Monica Defend discusses the market reaction to Keir Starmer's announcement that he will step down as British prime minister. Speaking on Bloomberg Television, she says "this was largely expected," which justifies the "containment in volatility." Defend adds there is still value on the yield and that "the real story is one of fiscal discipline."